UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference

European journal of pharmaceutical sciences, 2023-11, Vol.190, p.106566-106566, Article 106566

2023

Volltextzugriff (PDF)

Highly sensitive reflection based colorimetric gas sensor to detect CO in realistic fire scenarios

Sensors and actuators. B, Chemical, 2020-03, Vol.306, p.127572, Article 127572

2020

Volltextzugriff (PDF)

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference

European journal of pharmaceutical sciences, 2021-12, Vol.167, p.105987-105987, Article 105987

2021

Volltextzugriff (PDF)

Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-01, Vol.814 (2), p.217-223

2005

Volltextzugriff (PDF)

The biopharmaceutics classification system (BCS): Class III drugs — better candidates for BA/BE waiver?

European journal of pharmaceutical sciences, 1999-12, Vol.9 (2), p.117-121

1999

Volltextzugriff (PDF)

The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag‐time after a high fat breakfast

British journal of clinical pharmacology, 2002-06, Vol.53 (6), p.582-588

2002

Volltextzugriff (PDF)

Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast

European journal of clinical pharmacology, 2002-05, Vol.58 (2), p.119-125

2002

Volltextzugriff (PDF)

Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration

International journal of clinical pharmacology and therapeutics, 2010-02, Vol.48 (2), p.158-170

2010

Volltextzugriff (PDF)

Phenotyping with sulfasalazine - time dependence and relation to NAT2 pharmacogenetics

International journal of clinical pharmacology and therapeutics, 2010-01, Vol.48 (1), p.1-10

2010

Volltextzugriff (PDF)

Dose-proportionality of oral thioctic acid — coincidence of assessments via pooled plasma and individual data

European journal of pharmaceutical sciences, 1999-04, Vol.8 (1), p.57-65

1999

Volltextzugriff (PDF)

Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources

International journal of clinical pharmacology and therapeutics, 2009-06, Vol.47 (6), p.405-412

2009

Volltextzugriff (PDF)

Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations

Journal of pharmacy and pharmacology, 2002-11, Vol.54 (11), p.1507-1514

2002

Volltextzugriff (PDF)

Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union

International journal of clinical pharmacology and therapeutics, 2006-01, Vol.44 (1), p.38-48

2006

Volltextzugriff (PDF)

Formulations of Fentanyl for the Management of Pain

Drugs (New York, N.Y.), 2010, Vol.70 (1), p.57-72

2010

Volltextzugriff (PDF)

MON-P245: New High Protein and High Energy Oral Nutritional Supplement for Compliance and Tolerance in Elderly Care

Clinical nutrition (Edinburgh, Scotland), 2017-09, Vol.36, p.S268-S268

2017

Volltextzugriff (PDF)

Characterization of the behavior of alginate-based microcapsules in vitro and in vivo

International journal of clinical pharmacology and therapeutics, 2009-09, Vol.47 (9), p.556-563

2009

Volltextzugriff (PDF)

Influence of food intake on the bioavailability of thioctic acid enantiomers

European journal of clinical pharmacology, 1996, Vol.50 (6), p.513-514

1996

Volltextzugriff (PDF)

Lack of interaction between thioctic acid, glibenclamide and acarbose

British journal of clinical pharmacology, 1999-12, Vol.48 (6), p.819-825

1999

Volltextzugriff (PDF)

Biopharmaceutical characterisation of herbal medicinal products : are in vivo studies necessary?

European journal of drug metabolism and pharmacokinetics, 2000-01, Vol.25 (1), p.41-48

2000

Volltextzugriff (PDF)

Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation

International journal of clinical pharmacology and therapeutics, 1999-08, Vol.37 (8), p.386

1999

Volltextzugriff (PDF)

Bioequivalence study of two morphine extended release formulations after multiple dosing in healthy volunteers

International journal of clinical pharmacology and therapeutics, 1999-03, Vol.37 (3), p.153

1999

Volltextzugriff (PDF)

Untersuchung zur Magenverweilzeit von ProvideXtra® DRINK in gesunden Probanden

Aktuelle Ernährungsmedizin, 2008, Vol.33 (3)

2008

Volltextzugriff (PDF)

Vergleich der Bioverfügbarkeiten von Erythromycinestolat bzw. Erythromycinethylsuccinat enthaltenden Trockensaft-Zubereitungen im steady state

Pharmazie, 1995, Vol.50 (1), p.56-60

1995

Volltextzugriff (PDF)

Regionalization of sorption capacities for arsenic and cadmium

Plant and soil, 1999-01, Vol.213 (1/2), p.181-187

1999

Volltextzugriff (PDF)

Neue Richtlinien für die Beurteilung der Bioverfügbarkeit/Bioäquivalenz

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2005-05, Vol.48 (5), p.548-555

2005

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Englisch
(247)
Deutsch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference

Highly sensitive reflection based colorimetric gas sensor to detect CO in realistic fire scenarios

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference

Felodipine quantification in human plasma by high-performance liquid chromatography coupled to tandem mass spectrometry

The biopharmaceutics classification system (BCS): Class III drugs — better candidates for BA/BE waiver?

The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag‐time after a high fat breakfast

Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast

Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration

Phenotyping with sulfasalazine - time dependence and relation to NAT2 pharmacogenetics

Dose-proportionality of oral thioctic acid — coincidence of assessments via pooled plasma and individual data

Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources

Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations

Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union

Formulations of Fentanyl for the Management of Pain

MON-P245: New High Protein and High Energy Oral Nutritional Supplement for Compliance and Tolerance in Elderly Care

Characterization of the behavior of alginate-based microcapsules in vitro and in vivo

Influence of food intake on the bioavailability of thioctic acid enantiomers

Lack of interaction between thioctic acid, glibenclamide and acarbose

Biopharmaceutical characterisation of herbal medicinal products : are in vivo studies necessary?

Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation

Bioequivalence study of two morphine extended release formulations after multiple dosing in healthy volunteers

Untersuchung zur Magenverweilzeit von ProvideXtra® DRINK in gesunden Probanden

Vergleich der Bioverfügbarkeiten von Erythromycinestolat bzw. Erythromycinethylsuccinat enthaltenden Trockensaft-Zubereitungen im steady state

Regionalization of sorption capacities for arsenic and cadmium

Neue Richtlinien für die Beurteilung der Bioverfügbarkeit/Bioäquivalenz

Suchergebnisse filtern